wallstreetnewscast: $TWSI revenues up 70% on medical sales

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

wallstreetnewscast Newsletter

Wall Street Newscast Traders Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~


TWSI Revenues Rise 70% to $4.4 Million, Losses Decrease (NEW YORK)–Tristar Wellnes Solutions, Inc. (OTC:TWSI), a leading developer and marketer of advanced medical products, reported revenues grew nearly 70% on nine month bases as overall earnings performance improves.

Three Month Results For the three months ended September 30, 2014, the Company reported revenues rose roughly 50% to $1,908,000, as compared to $1,281,000 for the three months ended September 30, 2013.

In addition to improving revenues, the Company reported a 66% decrease in operating loss for the quarter to approximately $501,000, compared to an operating loss of approximately $1,513,000 for the three months ended September 30, 2013.

Nine Month Results For the nine months ended September 30, 2014, revenues rose roughly 70% to $4,435,000, as compared to $2,574,000 for same period in 2013, while our operating loss decreased 35% to $2,993,000, from $4,685,000 in the same nine month period in 2013.

Purchase Deal with NASDAQ Company In November 2014, the Company announced it was awarded a group purchasing agreement with NASDAQ listed Premier, Inc. (NASDAQ:PINC), a leading healthcare supply company, for Hemostasis and Compression products. This agreement, along with our current marketing and distribution networks, should continue to have a positive effect in building our top-line revenue growth for both the fourth quarter, and fiscal 2015.

US Military Sales and Recommendation On April 10, 2014, the Company announced that the U.S. Department of Defense`s Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations for control of severe external hemorrhage to include HemCon`s ChitoGauze hemostatic chitosan-coated gauze product. Having the US Military recommending TWSI product as an effective product for combat use could mean even larger sales contracts in the coming quarters.

About HemCon HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic.

For more information, please visit www.hemcon.com ~~~~~~~~~~~~~~~~~~~~~~~~~~

About Wall Street Newscast Located in New York City, Wall Street Newscast (WSNC) has been providing Wall Street investor presentations for both public and private companies since 1998. WSNC offers a wide-range of services to companies and investor relation professionals to discuss their recent news announcements, earnings reports, and corporate events to a diverse network of individual and institutional investors on Wall Street.www.wallstreetnewscast.com Register online for our free traders newsletter at www.wallstreetnewscast.com/form/newsletter.html ~~~~~~~~~~~~~~~~~~~~~~~~~~


Safe Harbor Statements:

This investor presentation may include statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.


This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast (“WSNC“) does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was compensated by the Company for media exposure. WSNC may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.


Forward this email

This entry was posted in Stock Newsletters and tagged , , . Bookmark the permalink.

Comments are closed.